For the Inventor, By the Inventor

Enter assignee name

Danbury, CT, United States of America

Mannkind Corporation

USPTO Granted Patents = 286

% Expired Patents = 18.2

CIPO Patents = 21

EPO Patents = 78

Forward Citations = 4,729

Loading Chart...

Loading Chart...

153 inventors (with patents filed for the assignee):

Chad C Smutney (65 out of 76 patents)

Benoit Adamo (60 out of 90 patents)

P Spencer Kinsey (57 out of 72 patents)

4. John M Polidoro (38 out of 63 patents)

5. Marshall L Grant (34 out of 34 patents)

6. Carl R Sahi (29 out of 48 patents)

7. Solomon S Steiner (26 out of 59 patents)

8. Kelly Sullivan Kraft (22 out of 27 patents)

9. Trent A Poole (22 out of 38 patents)

10. John J Freeman (21 out of 34 patents)

11. Dennis Overfield (21 out of 21 patents)

12. Bryan R Wilson (20 out of 25 patents)

13. Scott McLean (19 out of 88 patents)

14. Andrea Leone-Bay (18 out of 118 patents)

15. Brendan F Laurenzi (18 out of 19 patents)

Core Competencies:

Dry Powder Inhaler

Fluid Delivery Device

Diketopiperazine

Diabetes Treatment

Pharmaceutical Composition

Cryogranulation

Ultrarapid Acting Insulin

Microparticles

Drug Formulation

Prefilled Cartridge

Blister Package

286 patents: Sort by Forward Citations

1. 12734291 - Time delay mechanism for a hydraulic drug delivery device (2026-09-15),

2. 12728216 - Apparatus, system and method for detecting and monitoring inhalations (2026-09-08),

3. 12679811 - Microcrystalline diketopiperazine compositions and methods (2026-07-14),

4. 12673153 - Fluid delivery device (2026-07-07),

5. 12582784 - Dry powder inhalation system (2026-03-24),

6. 12576093 - Pharmaceutical composition for subcutaneous administration (2026-03-17),

7. 12576009 - Adapter for a fluid transfer device (2026-03-17),

8. 12521492 - Communication accessory for a drug delivery device (2026-01-13),

9. 12508376 - Dry powder inhaler (2025-12-30),

10. 12465681 - Cartridge insertion mechanism for a fluid delivery device (2025-11-11),

11. 12459903 - Formation of n-protected 3,6-bis-(4-aminoalkyl)-2,5,diketopiperazine (2025-11-04),

12. 12453702 - Apparatus and method for cryogranulating a pharmaceutical composition (2025-10-28),

13. 12447293 - Dry powder inhaler and system for drug delivery (2025-10-21),

14. 12440620 - Moving basal engine for a fluid delivery device (2025-10-14),

15. 12433889 - Compositions of clofazimine, combinations comprising them, processes for their preparation, uses and methods comprising them (2025-10-07),

MannKind Corporation is a biopharmaceutical company that focuses on the development and commercialization of therapeutic products for patients with diseases such as diabetes. Their flagship product, Afrezza, is an inhaled insulin used to improve glycemic control in adults with diabetes mellitus. MannKind Corporation strives to advance healthcare solutions through innovative and accessible treatments.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Sep 22 2026

Mannkind Corporation

286 Patents

#4 in Danbury, CT

#44 in Connecticut

#1,527 in US

#3,090 in the World

Danbury, CT, United States of America

Mannkind Corporation

Forward Citations = 4,729

153 inventors:

Chad C Smutney (65 out of 76 patents)

Benoit Adamo (60 out of 90 patents)

P Spencer Kinsey (57 out of 72 patents)

4. John M Polidoro (38 out of 63 patents)

5. Marshall L Grant (34 out of 34 patents)

Please report any incorrect information to [email protected]

Loading…